NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Operating cash flow, 2025
- $5.2M
- YoY, 2025
- −25.5%
- 5-year CAGR
- +29.1%
- 10-year CAGR
- −2.0%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $5.2M | −25.5% |
| 2024 | $7.0M | — |
| 2023 | −$2.0M | — |
| 2022 | −$66M | — |
| 2021 | −$27M | — |
| 2020 | $1.5M | −93.8% |
| 2019 | $23M | −47.8% |
| 2018 | $45M | +148.3% |
| 2017 | $18M | −16.0% |
| 2016 | $21M | +235.9% |
| 2015 | $6.4M | −32.3% |
| 2014 | $9.5M | +324.3% |
| 2013 | $2.2M | — |
| 2012 | −$492K | — |
| 2011 | $69K | — |
| 2010 | −$2.1M | — |